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ABSTRACT

-

Information gained in these studies seems to indicate the possibility that t~e K-562
cell line may partially differentiate to B- cells. It was first shown in previous
experiments that anti-hlgMkilis K..562 cells. The anti-hlgM also bound to the cells,
which indicates that IgM is expressed on the surface of the K-562 cell. Anti-hlgM kills
all of the K-562 cells within four hours. A later experiment showed the possibility of
patching and capping occurring with anti-hlgM on the surface of the K-562 cell. The
antigenic expression of the K-562 cell did not change after treatment with anti-hlgM.

,.

To try to save the cell from the anti-hlgM induced death, IgM was added to the cells.
The hypothesis was that the anti-hlgM would bind to the IgM, and, therefore, be unable
to bind to the cell and cause death. However, the results showed that the IgM was
toxic to the cell as well and, when added with anti-hlgM, enhanced the toxicity.

...

Anti-hlgO was also teste~ to determine its effect on the K-562 cell.' It was toxic to the
cell. This offers the possibility of more evidence of the K-562 cell line'. expressing
characteristics of immature B- cells. If the anti-hlgO binds to the cell, it would show
that both IgM and IgO are expressed,on the cell surface. These data show that (a)
Both anti-hlgM and anti-hlgO are toxic to the K-562 cell (b) Anti-hlgM binds to the K
562 cell (c) IgM does not save the cell from anti-hlgM induced death (d) There is
evidence supporting the possibility of apoptosis as the mechanism of cell death (e)
There is some evidence suggesting patching and capping of anti-hlgM on the surface
of the K-562 cell (f) These K-562 cells show some characteristics normally associated
with B-cells.
INTRODUCTION
The K-562 cell line is a human cell line isolated from the pleural effusion of a patient
with chronic myelogenous leukemia in terminal blast crisis (1). K-562 can be caused
to undergo partial differentiation into erythrocytic, granulocytic, lymphocytic, monocytic,
and megakaryocytic lineages by several inducers (2).

However, K-562 has never

been shown to partially differentiate into a B- cell. These studies seem to indicate this
as a possibility. A B- cell has been shown to have IgO and IgM on its surface.
Normally, only IgM is expressed in the early stages of differentiation. IgD is only
Wendy Bradberry 1

-

-

expressed in the later stages, mostly on mature B- cells. Both anti-hlgM and anti-hlgD
have been shown to be toxic to the K-562 cell. Anti-lgM does bind to the K-562 cell,
but it is not yet known if the anti-hlgD will bind. If the anti-lgD binds, it would

~eem

likely that over the course of many passages, the K-562 cell has acquired certain

-

characteristics normally associtated with B-cells.
MATERIALS AND METHODS
Reagents
Thu following reagents and media were used: Goat F(ab')2 Anti Human IgM (TAGO,
INC. Burlingame, CA); Standard Immunophenotyping Monoclonals (Becton Dickinson
Immunocytometry Systems); RPMI 1640 + 10% Fetal Calf Serum; RPMI 1640 + 1%
Nutridoma (Boehringer Mannheim Corporation, Indianapolis, IN); hlgM (Sigma
Immuno Chemicals, St. Louis, MO); hlgG (Sima Immuno Chemicals, St. Louis, MO);
and Goat F(ab')2 Anti Human IgD (TAGO, INC, Burlingame, CA)

This figure shows the difference between
the complete antibody and the F(ab')2 frag
ments used in these experiments.
F(abj' Fragmtlnls
IRuslrallCl is a Vfsvaliza,ion o( IJndtI!!Siftld
/JInding at an F. receptor. To atlOId
afltlxxly bind1ll9 to Fe receptor Siltls.
TAGO providt/s F(s01t (ragmefll!!S lor
u.sa,., r«JUiring tlltquisitlJ SlIfISilMty
and Specificity•.
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Fresh K-562 celfs were obtained from Dr. Lozzio every week to assure that the
cell line remained the same throughout the experiments. The cells were used during
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the log phase of growth. A concentration of 3.75 x 104 cells/ml were used in each
experim ent.
Determination of the Toxicity of Anti-hlgM
K-562 cells in logarithm ic growth phase were adjusted to a concentration of 3.75 x
104 cells per milliliter. Two plates were prepared. The first two rows of each plate

..

were cell controls. Fifty microliters of RPMI 1640 + 100/0 Fetal Calf Serum was added
to all wells except the first well of rows C,D,E,F,G, and H of both plates. In well one of
.,.

these rows, one hundred microliters of : anti-hlgM + azide in rows C,D, and E of plate
1; anti-hlgM - azide in rows F,G, and H of plate 1; anti-CD33 + azide in rows C,D, and E
of plate 2; anti-CD33 - azide in rows F,G, and H of plate 2. 100 microliters of K..562
cells were added to all 96 wells. This was incubated at 37 degrees Celsius for 48

..

hours. 50 microliters of tritiated Thymidine was then added to pre-label the samples .
The cells were incubated for three more hours. The.cells were then harvested onto
glass fiber filter paper and the results were quantitated with a liquid scintillation
counter (Beckman Instruments, Inc, Norcross, Georgia.)
Determination of Binding of the K-562 Cell to Anti..hlgM and the Antigenic Profile of the
K-562 Cell
The Monoclonal and Leukem ia panels shown below were used to determ ine if anti ..
hlgM binds to the cell. This same panel was used to determine the antigenic profile of
the K-562 cell. The appropriate amount of monoclonal was added to each tube, then
.1 ml of K-562 cells were added. The tubes were incubated in the dark at room
temperature for fifteen minutes. Two ml of phospate buffered saline (PBS) without
calcium and magnesium containing 0.1 % Sodium Azide was then added to each tube.
They were then vortexed and centrifuged at 250 x g for five minutes. The supernatant
fluid was aspirated and .5 ml of 1% paraformaldehyde was added to each tube. They
were vortexed. The preparations were stored at four degrees Celcius until they were
analyzed on the FACScan (Becton Dickinson Immunocytometry.)
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Protocol for two color analysis studies.
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..
..

Monoclonal Panel
1. Simultest LeucoGATE

(FITC-CD45/PE-CD14)

2. Simultest Control gamma 1/gamma 2a
3. Simultest CD4/CD8

(FITC..Leu3/PE-Leu2)

4. Simultest CD3/CD19

(FITC-Leu4/PE..Leu 12)

5. Simultest CD3/Anti-HLA-DR

(FITC-Leu4/PE-anti-H LA-DR)

6. Simultest CD57/CD8

(FITC..Leu7/PE..Leu2)

7. Simultest CD3/CD16 + CD56

(FITC-Leu4/PE-Leu11c + 19)

8. Combination CD2ICD20

(FITC-Leu5b/ + PE-Leu 16)

9. Combination CD2/CD25

(FITC-Leu5b/ + PE-anti-IL-2R)

10. Combination anti-TCRlCD3

(FITC-Leu-anti-TCR/ + PE-Leu 4)

11. Simultest CD3/CD8

(FITC-Leu4/PE-Leu2)

12. Simultest CD3/CD4

(FITC-Leu4/PE-Leu3)

13. Combination anti-hlgm/CD20

·(FITC-anti-hlgMlPE-Leu 16)

Leukemia Panel
14. Simultest anti-Kappalanti-Lambda

(FITC-KappalPE-Lambda B-D)

15. Combination CD15/CD33

(FITC-LeuM1 + PE-LeuM9)

16. Combination CD10/Cd20

(FITC-CAL~

17. Combination CD2ICD5

+ PE-Leu16)
(FITC-Leu5b + PE-Leu1)

18. Combination CD34/CD20

(FITC-CD34 + PE..Leu 16)

19. Polyclonal control

Tago (1: 10 dilution, 50 microliters)

20. Polyclonal kappa/lambda

Tago (FITC ..Kappa + PE-Lambda)

21. Combination CD14/CD33

(FITC-LeuM3 + PE-Leu-M9)

Determination of the Timecourse of anti-hlgM Killing of K-562 Cells
One plate was prepared. All rows contained in wells 1-6 100 microliters of media
and 50 microliters of K-562 cells at a concentration of 3.75 x 104 . In wells 7-12 there
was 100 microliters of anti-hlgM and 50 microliters of cells. The plate was then
Wendy Bradberry 4

incubated at 37 degrees Celcius. One row was treated with 50 microliters of tritiated
thymidine at each of the following time points: 4 hours, 8 hours, 24 hours, 28 hours, 32
hours, and 48 hours. The rows were harvested three hours after the time at which the
tritiated thymidine was added. The cells were harvested onto glass fiber filte'r paper.
Radioactivity was quantified with a liquid scintillation counter.

,.

Determination of Anti-hlgM Toxicity in Fetal Calf Serum and Nutridoma
One plate was set up. Row A contained 50 microliters of RPMI 1640 + 10% Fetal
..

Calf Serum (FCS) and 100 microliters of K-562 cells grown in FCS. Row B contained
50 microliters of RPMI 1640 + 1% Nutridoma (N) and 100 microliters of K-562 cells
grown in Nutridoma media.

Rows

C,~,

and E contained 50 microliters of FCS in

wells 2-12, 100 microliters of anti-hlgM in well 1, 50 microliter serial dilutions were
done, and 100 microliters of K-562 cells in FCS were added. Rows F,G, and H
contained 50 microliters!fp N in wells 2-12, 100 microliters of anti-hlgM in well 1,' 50
microliter serial dilutions were done and 100 microliters of K-562 cells were added.
The plate was incubated at 37 degrees Celsius for 48 hours. The cells were treated
with 50 microliters of tritiated Thymidine. Three hours later, they were harvested onto
glass fiber filter paper, and then raioactivity was quantified with a liquid scintillation
counter.
Determination of the Antigenic Profile Before and After Treatmenfwith Anti-hlgM
The same panel was used that was shown in the experiment to determ ine if Anti
hlgM bound to the K-562 cell. The same procedure was run on the panel. Two of
these panels were done; one containing untreated K..562 cells and one containing
cells that had been treated with anti-hlgM.
Determination of the effect of hlgM on anti..hlgM Induced Cell Death
One plate was set up. Row A contained 100 microliters of FCS and 100 microliters
of K-562 cells. Row B contained 50 microliters of FCS, 50 microliters of hlgM, and 100
Wendy Bradberry 5
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microliters of K-562 cells. Rows C,D, and E contained 50 microliters of FCS in wells 2
12, 100 microliters of hlgM in well 1, 50 microliter serial dilutions were done, 50 more
microliters of FCS were added, and 100 microliters of K-562 cells were added. Rows
F,G, and H contained 50 microliters of FCS in wells 2-12, 100 microliters of hlgM in
well 1, 50 microliter serial dilutions were done, 50 microliters of anti-hlgM was added,
and 100 microliters of K-562 cells were added. The plate was incubated at 37
degrees Celcius for 48 hours. The cells were then tritiated and harvested three hours
later. Quantitative results were obtained from a liquid scintillation counter.
Determination of the Effect of IgM on anti-hlgM Binding to the K-562 Cell
Three test tubes were set up.
Test Tube 1: 20 microliters anti-CD20
20 microliters anti-hlgM (.89 mg/ml)
20 microliters of IgM (1mg/ml)
Test Tube 2: 20 microliters anti-CD20
20 microliters anti-hlgM
40 microliters IgM
Test Tube 3: 20 microliters anti-CD20
20 microliters anti-hlgM
80 microliters IgM
0.1 ml of K-562 cells were added to each tube. The admixture was incubated at room
temperature in the dark for fifteen minutes. They were then washed with 2 ml of
phospate buffered saline without calcium and magnesium containing 0.1 % sodium
azide, vortexed, and centrifuged at 250 x g for 5 minutes. The supernatant fluid was
aspirated and .5 ml of 1% paraformaldehyde was added to each tube and vortexed.
Preparations were stored at 4 degrees Celsius until analyzed by FACScan.
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Determination of the Binding of Anti-hlgM to K-562 Cells at Different Times
petermination of Patching and Capping
Fou r sets of identical tubes were set up. Each set contained one of each of the
following tubes:
1. 20 microliters anti-CD4-FITC
20 microliters anti-CD8-PE
2. 20 microliters anti-CD20-PE
20 microliters anti-hlgM-FITC
The first tube in each set serves as a negative control since neither bind to the K-562
cell. K-562 cells were added at different time points so that the percent of cells positive
for anti-hlgM binding could be obtained for the following time periods: 15 minutes, 60
minutes, 105 minutes and 165 minutes. The results were obtained by analysis by
FACScan.
Determination of the Effect of IgG on K-562 Cells
A single plate was set up. Rows A and B were cell controls which contained 50
microliters of media and 100 microliters of K-562 cells. Rows C,D, and E contained
media in wells 2-12 and 100 microliters of IgM in one. 50 microliter serial dilutions
were done and 100 microliters of K-562 cells were added. Rows F,G, and H contained
50 microliters of media in wells 2-12 and 100 microliters of anti-hlgG in 1. 50 microliter
serial dilutions were done and 100 microliters of K-562 cells were added. 50
microliters of tritiated Thymidine was added after 48 hours of incubation at 37 degrees
Celcius. 3 hours later, the cells were harvested onto glass fiber filter paper and
analyzed by a liquid scintillation counter.

Determination of the Effect of Anti-hlgD on K-562 Cells
A single assay plate was set up. Rows A and B were cell controls containing 50
microliters of FCS and 100 microliters of K-562 cells. Rows C,D, and E contained 50
microliters of FCS in wells 2-12 and 100 microliters of anti-hlgD + azide in well 1. 50
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microliter serial dilutions were done and 100 microliters of K-562 cells were added.

-

Rows F, G, and H contained 50 microliters of FCS in wells 2-12 and 100 microliters of
anti-hlgD - azide in well 1. 50 microliter serial dilutions were done and 100' r:nicroliters
of K-562 cells were added. The plate was incubated at 37 degrees Celsius for 48
hours. 50 microliters of tritiated thymidine were added and 3 hours later, the plate was

,.

harvested and counted by a liquid scintillation counter.

RESULTS

Toxicity of Anti ..hlgM on K.. 5.62 Cells
Anti-hlgM was shown to be toxic in preliminary experiments done in Dr. Ichiki's lab.
These experiments were repeated and the same results were obtained. The following
graph shows the results of this initial experiment.

Monoclonal Toxicity (48 hour incubation)

Monoclonal Toxicity (24 hour incubaLion)
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Since the toxicity curves for anti-hlgM, anti-lambda, and anti-CD33 were all exactly the
same, there was the possibility of some common factor being the cause of cell death.
Upon examination, it was determined that all three contained the same concentration
-

of Sodium Azide. The following graph shows the effect of Sodium Azide on the K-562
cell.

•

Effect of Sodium Azide on K-562 cells
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Obviously, the toxicity previously observed was due to the Sodium Azide. Therefore,
the next step was to remove the Sodium Azide to see if the anti-hlgM remained toxic to
the cell. The results from this experiment confirm that anti-hlgM is toxic to the cell in
the absence of Sodium Azide. The first experiment done to show the toxicity of anti
hlgM in the absence of Sodium Azide used anti-CD4 as the control. Anti-CD4 is not
toxic to the K-562 cell, but it is also known that it does not bind to the K-562 cell. Since
anti-hlgM does bind to the K-562 cell, a better control would be one that did bind, but
was not toxic. Therefore, a second toxicity experiment was done using CD33 as a
control. It was known that the Sodium Azide was successfully removed, since CD33
was no longer toxic to the cell. The following graph shows the toxicity of anti-hlgM
after the removal of Sodium Azide.
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Toxicity of Anli-hlgM Using CD33 as a Control
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Binding of Anti-hlgM to the K-562 Cell
The K-562 cell was 42% positive for both anti-CD20 and anti-hlgM. It was 2%
positive for just anti-hlgM. These

result~

are from only one time point (15 minutes.)

The results from a subsequent experiment which is discussed later shows several time
points for the binding of anti-hlgM to the K-562 cell. In this experiment, at 15 minutes
80.570/0 of the cells were positive for anti-CD20 and anti-hlgM. It can be concluded
from both of these sets of data that anti-hlgM does bind to the K-562 cell.
Time course of K-562 Cell Death Due to Anti-hlgM
In an assay done to observe K-562 cells treated with anti-hlgM at different time
points, it was discovered that the anti-hlgM has induced death by four hours. The
following graph shows the time course for cell death.
Timecourse of anti-IgM Killing of K-562 cells
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Several observations were made about the phenotype of the K-562 cell after treatment
with anti-hlgM. Pictures 1,2, and 3 are untreated cells and pictures 4,5,and 6 are
treated cells. The treated cells show both blebbing and condensation of chromatin.
This suggests that the cell death induced by anti-hlgM might be occurring by apoptosis
of the cell. Both of these phenotypic characteristics are common in apoptotic cells.
Further analysis will have to be done to determine whether or not this is truly the
mechanism of cell death.
Toxicity of Anti-hlgM in Fetal Calf Serum Compared to Nutridoma
RPMI 1640 with 1% Nutridoma has the minimal growth factors necessary to sustain

'.

life, while RPMI 1640 with 100/0 Fetal Calf Serum has' an excess of growth factors. The
hypothesis previous to this experiment was that a lower concentration of anti-hlgM
would kill the cells if they were grown in Nutridoma rather than Fetal Calf Serum. If this
had proved to be true, it would have been more cost efficient to use the Nutridoma.
However, the results show that the toxicity curve is the same for both Fetal Calf Serum
and Nutridoma. The following graph shows these results.
CYI~toxicity of tlnti-IgM in RPM J 1640 + 10% Petal Calf Serum
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Antigenic Profile of the K-562 Cell

The antigenic profile of the K-562 Cell both before and after treatment with anti
hlgM was. observed. It did not change any after the treatment with the anti-hlgM. The
following tables show the fingerprint of the K-562 cell before and after treatment with
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anti-hlgM.
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Effect of hlgM on Anti-hlgM Induced Cell Death

It was expected that hlgM would bind to anti-hlgM and prevent it from binding and/or
killing the pell. The results showed that hlgM did not save the cell from anti-hlgM
induced death. It actually killed the cell itself. IgM enhanced the toxicity of anti-hlgM
Wendy Bradberry 12
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when they were added together. The following graph shows the toxicity of hlgM and
the toxicity of anti-hlgM in the presence of hlgM .

Effect of IgM on anti-IgM induced death of K-562 Cells
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Patching and Capping
In the ?nti-hlgM binding experiment, it was shown. that around 50% of the cells did
bind. In this experiment, binding was only tested at fifteen minutes. Since 100% of the
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cells are killed by anti-hlgM, it is of some interest to see if 100% of the cells are ever
bound to the anti-hlgM. It was found in an experiment done using four different time
points that the percentage of the bound cells shifts in a way that suggests pat<?hing and
capping is most likely occurring. In the patching and capping process, the anti-hlgM
would bind to the cell and then later would be taken inside the cell, while the receptors
returned to the surface. This would explain the varying percentage of cells bound to
anti-lgM at different time points. This is one possibility that may explain the results.
However, this explanation has not been confirmed. There is Sodium Azide present in
the monoclonals. Sodium Azide is an inhibitor of the patching and capping procedure
,t

since it is an ATP dependent process. The concentration' of Sodium Azide present
. might not have been high enough to prevent this process from occurring. Further
analysis will have to be done in order to determine the effect that the Sodium Azide
may have had on the process. The following figures show the binding at fifteen, sixty,
one-hundred five, and

one-~undred

sixty-five minutes.
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Effect of IgG on K-562 Cells
Since both anti-hlgM and anti-hlgD are toxic to the K-562 cell, another of the Ig

-

molecules was tested to see the effect. IgG did not have an effect on the cell. "The
following graph shows the results of the IgG experiment.
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Effect of Anti-hlgD on K-562 Cells
Anti-hlgD was found to be toxic to the cells. Since both anti-hlgD and anti-hlgM are
toxic to the cell, there is a possibility that these cells are immature B cells.

Future

experiments will determine if the anti-hlgD binds to the cell. The following graph shows
the toxicity of anti-hlgD on K-562 cells .
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Toxicity of Anli·hlgM and Anti.hlgD
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Below is a graph showing the toxicity of both anti-hlgM and anti-hlgO. The anti-hlgM is
t

obviously more toxic to the K-562 cell.
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